Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001179110-13-008511)

Filing Details

Accession Number:: 0001179110-13-008511
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2013-05-15 21:24:10
Reporting Period:: 2013-05-14

Filing Date:: 2013-05-15
Accepted Time:: 2013-05-15 20:24:10
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
919722	Astex Pharmaceuticals Inc	ASTX	Pharmaceutical Preparations (2834)	911841574

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1236365	J S James Manuso	C/O Astex Pharmaceuticals, Inc. 4140 Dublin Boulevard, Suite 200 Dublin CA 94568	Chief Executive Officer	Yes	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2013-05-14	29,500	$4.03	35,900	No	4	M	Direct
Common Stock	Disposition	2013-05-14	29,500	$5.84	6,400	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Director Stock Option (Right to buy)	Disposition	2013-05-14	29,500	$0.00	29,500	$4.03

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0	2003-05-22	2013-05-22	No	4	M	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	70	Indirect	See note

Footnotes

Includes 60 shares held individually by spouse and 10 shares held by spouse as custodian for their daughter under the Uniform Grant to Minors Act.